Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malaria

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    July 2025
  1. HALLETT TB, Menzies NA, Resch S, Pretorius C, et al
    The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study.
    Lancet. 2025 Jul 3:S0140-6736(25)00831-1. doi: 10.1016/S0140-6736(25)00831.
    PubMed     Abstract available


    June 2025
  2. SYMONS TL, Lubinda J, McPhail M, Saddler A, et al
    Estimating the potential malaria morbidity and mortality avertable by the US President's Malaria Initiative in 2025: a geospatial modelling analysis.
    Lancet. 2025;405:2231-2240.
    PubMed     Abstract available


  3. BOUM Y, Erondu NA
    Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa.
    Lancet. 2025;405:2184-2186.
    PubMed    


    May 2025
  4. ATERE AO, Mustapha FB, Mustapha MJ
    Logistics of the malaria vaccine roll-out in Nigeria.
    Lancet. 2025;405:1815.
    PubMed    


    March 2025
  5. LACERDA MVG, Bassat Q
    Mapping the malaria burden in the context of a global pandemic: progress, hiccups, and challenges.
    Lancet. 2025 Mar 5:S0140-6736(25)00418-0. doi: 10.1016/S0140-6736(25)00418.
    PubMed    


  6. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed     Abstract available


    February 2025
  7. KIRBY T
    Marcus Lacerda: aiming to eliminate vivax malaria.
    Lancet. 2025;405:456.
    PubMed    


    January 2025
  8. DATOO MS, Hill AVS, Beaumont E, Bradley J, et al
    The R21/Matrix-M malaria vaccine: questions remain - Author's reply.
    Lancet. 2025;405:299-301.
    PubMed    


  9. AABY P, Bjorkman A, Schapira A, Benn CS, et al
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:299.
    PubMed    


  10. OBARO S, Mokuolu O, Michelow IC
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:299.
    PubMed    


  11. LI Y, Liu G
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:298-299.
    PubMed    


  12. GONCALVES MADA, Morais H, Ribeiro Junior HL
    Malaria and undernutrition in Angola.
    Lancet. 2025;405:296-297.
    PubMed    


  13. IMPOUMA B, Adidja A, Mboussou F, Cabore J, et al
    Malaria vaccine introduction in Africa: progress and challenges.
    Lancet. 2025 Jan 21:S0140-6736(24)02841-1. doi: 10.1016/S0140-6736(24)02841.
    PubMed    


    December 2024
  14. OCHOMO EO, Gimnig JE, Awori Q, Abong'o B, et al
    Effect of a spatial repellent on malaria incidence in an area of western Kenya characterised by high malaria transmission, insecticide resistance, and universal coverage of insecticide treated nets (part of the AEGIS Consortium): a cluster-randomised,
    Lancet. 2024 Dec 19:S0140-6736(24)02253-0. doi: 10.1016/S0140-6736(24)02253.
    PubMed     Abstract available


  15. SWAI JK, Moore SJ
    Beyond repellents: spatial emanators for the control of malaria in Africa.
    Lancet. 2024 Dec 19:S0140-6736(24)02754-5. doi: 10.1016/S0140-6736(24)02754.
    PubMed    


    April 2024
  16. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
    Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
    Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
    PubMed     Abstract available


  17. DAUBENBERGER CA, Silva JC
    First-generation malaria vaccine successfully implemented in three African countries.
    Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
    PubMed    


    February 2024
  18. THE LANCET
    Malaria vaccines: a test for global health.
    Lancet. 2024;403:503.
    PubMed    


  19. ADEPOJU P
    Routine malaria vaccinations begin.
    Lancet. 2024;403:423.
    PubMed    


  20. MOORTHY V, Hamel MJ, Smith PG
    Malaria vaccines for children: and now there are two.
    Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
    PubMed    


  21. DATOO MS, Dicko A, Tinto H, Ouedraogo JB, et al
    Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
    Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
    PubMed     Abstract available


    January 2024
  22. NAKWEYA G
    Cabo Verde eliminates malaria.
    Lancet. 2024;403:341.
    PubMed    


  23. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    PubMed    


  24. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    PubMed     Abstract available


    November 2023
  25. ASSEFA A, Parr JB
    Universal radical cure: prospects and challenges for malaria elimination.
    Lancet. 2023 Nov 15:S0140-6736(23)01950-5. doi: 10.1016/S0140-6736(23)01950.
    PubMed    


  26. THRIEMER K, Degaga TS, Christian M, Alam MS, et al
    Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Lancet. 2023 Nov 15:S0140-6736(23)01553-2. doi: 10.1016/S0140-6736(23)01553.
    PubMed     Abstract available


  27. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    PubMed     Abstract available


    October 2023
  28. ADEPOJU P
    Malaria community welcomes WHO vaccine approval.
    Lancet. 2023;402:1316.
    PubMed    


    September 2023
  29. KESSY SA, Tibenderana JR
    Zanzibar's malaria elimination efforts: progress, challenges, and lessons.
    Lancet. 2023;402:774.
    PubMed    


  30. HAWLEY WA, Laihad FJ, Ochomo E, Achee NL, et al
    What constitutes high-quality evidence for malaria vector control?
    Lancet. 2023;402:773-774.
    PubMed    


    July 2023
  31. SAMARASEKERA U
    Climate change and malaria: predictions becoming reality.
    Lancet. 2023;402:361-362.
    PubMed    


  32. DEVI S
    12 countries to get first doses of malaria vaccine.
    Lancet. 2023;402:172.
    PubMed    


    May 2023
  33. ZAROCOSTAS J
    Gavi unveils malaria vaccine plans.
    Lancet. 2023;401:1485.
    PubMed    


    April 2023
  34. KEATING C
    Artesunate versus quinine: the controlled trials watershed.
    Lancet. 2023;401:1329-1331.
    PubMed    


  35. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available


    March 2023
  36. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.